With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...

"China market is one of the most attractive markets for Edwards," said Leo Tam, senior director of the business unit of Transcatheter Aortic Valve Replacement, Edwards Lifesciences China, citing a lot ...

Modifi Biosciences, Inc., has announced that the company has been acquired by Merck, known as MSD outside of the United ...

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

This year, pharmaceutical giant Merck (NYSE: MRK) is it: The drugmaker's shares are down by 2% in 2024 while the broader S&P 500 is up by 21%. Even when we zoom out, Merck hasn't performed ...

Bindra, MD, PhD, Modifi Biosciences co-founder, Harvey and Kate Cushing, Professor of Therapeutic Radiology at Yale School of Medicine, and Scientific Director of the Yale Brain Tumor Center at Smilow ...

Merck is acquiring the Yale-spinout, which develops direct DNA modification-enabled cancer treatments.

Professor of Therapeutic Radiology at Yale School of Medicine, and Scientific Director of the Yale Brain Tumor Center at Smilow Cancer Hospital. Merck has paid $30 million upfront and, as per the ...

In this exclusive podcast, experts in the field, Andrew Foy, Penn State Health Milton S. Hershey Medical Center, and Ed Filippone, Sidney Kimmel Medical College of Thomas Jefferson University, both in ...